Summary
According to APO Research, The global Lipid Nanoparticles (LNP) market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Lipid Nanoparticles (LNP) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Lipid Nanoparticles (LNP) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Lipid Nanoparticles (LNP) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Lipid Nanoparticles (LNP) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Lipid Nanoparticles (LNP) include Precision NanoSystems, Evonik, Merck KGaA, Genevant Sciences, Exelead, Avanti Polar Lipids, Nippon Fine Chemical and Lipoid, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Lipid Nanoparticles (LNP), market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Lipid Nanoparticles (LNP), also provides the revenue of main regions and countries. Of the upcoming market potential for Lipid Nanoparticles (LNP), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Lipid Nanoparticles (LNP) revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Lipid Nanoparticles (LNP) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Lipid Nanoparticles (LNP) revenue, projected growth trends, production technology, application and end-user industry.
Lipid Nanoparticles (LNP) segment by Company
Precision NanoSystems
Evonik
Merck KGaA
Genevant Sciences
Exelead
Avanti Polar Lipids
Nippon Fine Chemical
Lipoid
Lipid Nanoparticles (LNP) segment by Type
mRNA-lipid Nanoparticle
siRNA-lipid Nanoparticle
Others
Lipid Nanoparticles (LNP) segment by Application
Vaccines and Drugs
Scientific Research
Lipid Nanoparticles (LNP) segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lipid Nanoparticles (LNP) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lipid Nanoparticles (LNP) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lipid Nanoparticles (LNP).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Lipid Nanoparticles (LNP) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Lipid Nanoparticles (LNP) company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lipid Nanoparticles (LNP) revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 Lipid Nanoparticles (LNP) Market by Type
1.2.1 Global Lipid Nanoparticles (LNP) Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 mRNA-lipid Nanoparticle
1.2.3 siRNA-lipid Nanoparticle
1.2.4 Others
1.3 Lipid Nanoparticles (LNP) Market by Application
1.3.1 Global Lipid Nanoparticles (LNP) Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Vaccines and Drugs
1.3.3 Scientific Research
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Lipid Nanoparticles (LNP) Market Dynamics
2.1 Lipid Nanoparticles (LNP) Industry Trends
2.2 Lipid Nanoparticles (LNP) Industry Drivers
2.3 Lipid Nanoparticles (LNP) Industry Opportunities and Challenges
2.4 Lipid Nanoparticles (LNP) Industry Restraints
3 Global Growth Perspective
3.1 Global Lipid Nanoparticles (LNP) Market Perspective (2019-2030)
3.2 Global Lipid Nanoparticles (LNP) Growth Trends by Region
3.2.1 Global Lipid Nanoparticles (LNP) Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Lipid Nanoparticles (LNP) Market Size by Region (2019-2024)
3.2.3 Global Lipid Nanoparticles (LNP) Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global Lipid Nanoparticles (LNP) Revenue by Players
4.1.1 Global Lipid Nanoparticles (LNP) Revenue by Players (2019-2024)
4.1.2 Global Lipid Nanoparticles (LNP) Revenue Market Share by Players (2019-2024)
4.1.3 Global Lipid Nanoparticles (LNP) Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Lipid Nanoparticles (LNP) Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Lipid Nanoparticles (LNP) Key Players Headquarters & Area Served
4.4 Global Lipid Nanoparticles (LNP) Players, Product Type & Application
4.5 Global Lipid Nanoparticles (LNP) Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Lipid Nanoparticles (LNP) Market CR5 and HHI
4.6.2 Global Top 5 and 10 Lipid Nanoparticles (LNP) Players Market Share by Revenue in 2023
4.6.3 2023 Lipid Nanoparticles (LNP) Tier 1, Tier 2, and Tier 3
5 Lipid Nanoparticles (LNP) Market Size by Type
5.1 Global Lipid Nanoparticles (LNP) Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Lipid Nanoparticles (LNP) Revenue by Type (2019-2030)
5.3 Global Lipid Nanoparticles (LNP) Revenue Market Share by Type (2019-2030)
6 Lipid Nanoparticles (LNP) Market Size by Application
6.1 Global Lipid Nanoparticles (LNP) Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Lipid Nanoparticles (LNP) Revenue by Application (2019-2030)
6.3 Global Lipid Nanoparticles (LNP) Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 Precision NanoSystems
7.1.1 Precision NanoSystems Comapny Information
7.1.2 Precision NanoSystems Business Overview
7.1.3 Precision NanoSystems Lipid Nanoparticles (LNP) Revenue and Gross Margin (2019-2024)
7.1.4 Precision NanoSystems Lipid Nanoparticles (LNP) Product Portfolio
7.1.5 Precision NanoSystems Recent Developments
7.2 Evonik
7.2.1 Evonik Comapny Information
7.2.2 Evonik Business Overview
7.2.3 Evonik Lipid Nanoparticles (LNP) Revenue and Gross Margin (2019-2024)
7.2.4 Evonik Lipid Nanoparticles (LNP) Product Portfolio
7.2.5 Evonik Recent Developments
7.3 Merck KGaA
7.3.1 Merck KGaA Comapny Information
7.3.2 Merck KGaA Business Overview
7.3.3 Merck KGaA Lipid Nanoparticles (LNP) Revenue and Gross Margin (2019-2024)
7.3.4 Merck KGaA Lipid Nanoparticles (LNP) Product Portfolio
7.3.5 Merck KGaA Recent Developments
7.4 Genevant Sciences
7.4.1 Genevant Sciences Comapny Information
7.4.2 Genevant Sciences Business Overview
7.4.3 Genevant Sciences Lipid Nanoparticles (LNP) Revenue and Gross Margin (2019-2024)
7.4.4 Genevant Sciences Lipid Nanoparticles (LNP) Product Portfolio
7.4.5 Genevant Sciences Recent Developments
7.5 Exelead
7.5.1 Exelead Comapny Information
7.5.2 Exelead Business Overview
7.5.3 Exelead Lipid Nanoparticles (LNP) Revenue and Gross Margin (2019-2024)
7.5.4 Exelead Lipid Nanoparticles (LNP) Product Portfolio
7.5.5 Exelead Recent Developments
7.6 Avanti Polar Lipids
7.6.1 Avanti Polar Lipids Comapny Information
7.6.2 Avanti Polar Lipids Business Overview
7.6.3 Avanti Polar Lipids Lipid Nanoparticles (LNP) Revenue and Gross Margin (2019-2024)
7.6.4 Avanti Polar Lipids Lipid Nanoparticles (LNP) Product Portfolio
7.6.5 Avanti Polar Lipids Recent Developments
7.7 Nippon Fine Chemical
7.7.1 Nippon Fine Chemical Comapny Information
7.7.2 Nippon Fine Chemical Business Overview
7.7.3 Nippon Fine Chemical Lipid Nanoparticles (LNP) Revenue and Gross Margin (2019-2024)
7.7.4 Nippon Fine Chemical Lipid Nanoparticles (LNP) Product Portfolio
7.7.5 Nippon Fine Chemical Recent Developments
7.8 Lipoid
7.8.1 Lipoid Comapny Information
7.8.2 Lipoid Business Overview
7.8.3 Lipoid Lipid Nanoparticles (LNP) Revenue and Gross Margin (2019-2024)
7.8.4 Lipoid Lipid Nanoparticles (LNP) Product Portfolio
7.8.5 Lipoid Recent Developments
8 North America
8.1 North America Lipid Nanoparticles (LNP) Revenue (2019-2030)
8.2 North America Lipid Nanoparticles (LNP) Revenue by Type (2019-2030)
8.2.1 North America Lipid Nanoparticles (LNP) Revenue by Type (2019-2024)
8.2.2 North America Lipid Nanoparticles (LNP) Revenue by Type (2025-2030)
8.3 North America Lipid Nanoparticles (LNP) Revenue Share by Type (2019-2030)
8.4 North America Lipid Nanoparticles (LNP) Revenue by Application (2019-2030)
8.4.1 North America Lipid Nanoparticles (LNP) Revenue by Application (2019-2024)
8.4.2 North America Lipid Nanoparticles (LNP) Revenue by Application (2025-2030)
8.5 North America Lipid Nanoparticles (LNP) Revenue Share by Application (2019-2030)
8.6 North America Lipid Nanoparticles (LNP) Revenue by Country
8.6.1 North America Lipid Nanoparticles (LNP) Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Lipid Nanoparticles (LNP) Revenue by Country (2019-2024)
8.6.3 North America Lipid Nanoparticles (LNP) Revenue by Country (2025-2030)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Lipid Nanoparticles (LNP) Revenue (2019-2030)
9.2 Europe Lipid Nanoparticles (LNP) Revenue by Type (2019-2030)
9.2.1 Europe Lipid Nanoparticles (LNP) Revenue by Type (2019-2024)
9.2.2 Europe Lipid Nanoparticles (LNP) Revenue by Type (2025-2030)
9.3 Europe Lipid Nanoparticles (LNP) Revenue Share by Type (2019-2030)
9.4 Europe Lipid Nanoparticles (LNP) Revenue by Application (2019-2030)
9.4.1 Europe Lipid Nanoparticles (LNP) Revenue by Application (2019-2024)
9.4.2 Europe Lipid Nanoparticles (LNP) Revenue by Application (2025-2030)
9.5 Europe Lipid Nanoparticles (LNP) Revenue Share by Application (2019-2030)
9.6 Europe Lipid Nanoparticles (LNP) Revenue by Country
9.6.1 Europe Lipid Nanoparticles (LNP) Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Lipid Nanoparticles (LNP) Revenue by Country (2019-2024)
9.6.3 Europe Lipid Nanoparticles (LNP) Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 China
10.1 China Lipid Nanoparticles (LNP) Revenue (2019-2030)
10.2 China Lipid Nanoparticles (LNP) Revenue by Type (2019-2030)
10.2.1 China Lipid Nanoparticles (LNP) Revenue by Type (2019-2024)
10.2.2 China Lipid Nanoparticles (LNP) Revenue by Type (2025-2030)
10.3 China Lipid Nanoparticles (LNP) Revenue Share by Type (2019-2030)
10.4 China Lipid Nanoparticles (LNP) Revenue by Application (2019-2030)
10.4.1 China Lipid Nanoparticles (LNP) Revenue by Application (2019-2024)
10.4.2 China Lipid Nanoparticles (LNP) Revenue by Application (2025-2030)
10.5 China Lipid Nanoparticles (LNP) Revenue Share by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Lipid Nanoparticles (LNP) Revenue (2019-2030)
11.2 Asia Lipid Nanoparticles (LNP) Revenue by Type (2019-2030)
11.2.1 Asia Lipid Nanoparticles (LNP) Revenue by Type (2019-2024)
11.2.2 Asia Lipid Nanoparticles (LNP) Revenue by Type (2025-2030)
11.3 Asia Lipid Nanoparticles (LNP) Revenue Share by Type (2019-2030)
11.4 Asia Lipid Nanoparticles (LNP) Revenue by Application (2019-2030)
11.4.1 Asia Lipid Nanoparticles (LNP) Revenue by Application (2019-2024)
11.4.2 Asia Lipid Nanoparticles (LNP) Revenue by Application (2025-2030)
11.5 Asia Lipid Nanoparticles (LNP) Revenue Share by Application (2019-2030)
11.6 Asia Lipid Nanoparticles (LNP) Revenue by Country
11.6.1 Asia Lipid Nanoparticles (LNP) Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Lipid Nanoparticles (LNP) Revenue by Country (2019-2024)
11.6.3 Asia Lipid Nanoparticles (LNP) Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA Lipid Nanoparticles (LNP) Revenue (2019-2030)
12.2 MEALA Lipid Nanoparticles (LNP) Revenue by Type (2019-2030)
12.2.1 MEALA Lipid Nanoparticles (LNP) Revenue by Type (2019-2024)
12.2.2 MEALA Lipid Nanoparticles (LNP) Revenue by Type (2025-2030)
12.3 MEALA Lipid Nanoparticles (LNP) Revenue Share by Type (2019-2030)
12.4 MEALA Lipid Nanoparticles (LNP) Revenue by Application (2019-2030)
12.4.1 MEALA Lipid Nanoparticles (LNP) Revenue by Application (2019-2024)
12.4.2 MEALA Lipid Nanoparticles (LNP) Revenue by Application (2025-2030)
12.5 MEALA Lipid Nanoparticles (LNP) Revenue Share by Application (2019-2030)
12.6 MEALA Lipid Nanoparticles (LNP) Revenue by Country
12.6.1 MEALA Lipid Nanoparticles (LNP) Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Lipid Nanoparticles (LNP) Revenue by Country (2019-2024)
12.6.3 MEALA Lipid Nanoparticles (LNP) Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
List of Tables
Table 1. Global Lipid Nanoparticles (LNP) Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 1. mRNA-lipid Nanoparticle Major Manufacturers
Table 2. siRNA-lipid Nanoparticle Major Manufacturers
Table 3. Others Major Manufacturers
Table 4. Global Lipid Nanoparticles (LNP) Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Vaccines and Drugs Major Manufacturers
Table 6. Scientific Research Major Manufacturers
Table 7. Lipid Nanoparticles (LNP) Industry Trends
Table 8. Lipid Nanoparticles (LNP) Industry Drivers
Table 9. Lipid Nanoparticles (LNP) Industry Opportunities and Challenges
Table 10. Lipid Nanoparticles (LNP) Industry Restraints
Table 11. Global Lipid Nanoparticles (LNP) Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 12. Global Lipid Nanoparticles (LNP) Market Size by Region (2019-2024) & (US$ Million)
Table 13. Global Lipid Nanoparticles (LNP) Market Share by Region (2019-2024)
Table 14. Global Lipid Nanoparticles (LNP) Market Size by Region (2025-2030) & (US$ Million)
Table 15. Global Lipid Nanoparticles (LNP) Market Share by Region (2025-2030)
Table 16. Global Lipid Nanoparticles (LNP) Revenue by Players (US$ Million) & (2019-2024)
Table 17. Global Lipid Nanoparticles (LNP) Revenue Market Share by Players (2019-2024)
Table 18. Global Lipid Nanoparticles (LNP) Key Players Ranking, 2022 VS 2023 VS 2024
Table 19. Global Lipid Nanoparticles (LNP) Key Players Headquarters & Area Served
Table 20. Global Lipid Nanoparticles (LNP) Players, Product Type & Application
Table 21. Global Lipid Nanoparticles (LNP) Players Commercialization Time
Table 22. Global Players Market Concentration Ratio (CR5 and HHI)
Table 23. Global Lipid Nanoparticles (LNP) by Players Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 24. Global Lipid Nanoparticles (LNP) Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 25. Global Lipid Nanoparticles (LNP) Revenue by Type (2019-2024) & (US$ Million)
Table 26. Global Lipid Nanoparticles (LNP) Revenue by Type (2025-2030) & (US$ Million)
Table 27. Global Lipid Nanoparticles (LNP) Revenue Market Share by Type (2019-2024) & (US$ Million)
Table 28. Global Lipid Nanoparticles (LNP) Revenue Market Share by Type (2025-2030) & (US$ Million)
Table 29. Global Lipid Nanoparticles (LNP) Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 30. Global Lipid Nanoparticles (LNP) Revenue by Application (2019-2024) & (US$ Million)
Table 31. Global Lipid Nanoparticles (LNP) Revenue by Application (2025-2030) & (US$ Million)
Table 32. Global Lipid Nanoparticles (LNP) Revenue Market Share by Application (2019-2024) & (US$ Million)
Table 33. Global Lipid Nanoparticles (LNP) Revenue Market Share by Application (2025-2030) & (US$ Million)
Table 34. Precision NanoSystems Company Information
Table 35. Precision NanoSystems Business Overview
Table 36. Precision NanoSystems Lipid Nanoparticles (LNP) Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 37. Precision NanoSystems Lipid Nanoparticles (LNP) Product Portfolio
Table 38. Precision NanoSystems Recent Development
Table 39. Evonik Company Information
Table 40. Evonik Business Overview
Table 41. Evonik Lipid Nanoparticles (LNP) Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 42. Evonik Lipid Nanoparticles (LNP) Product Portfolio
Table 43. Evonik Recent Development
Table 44. Merck KGaA Company Information
Table 45. Merck KGaA Business Overview
Table 46. Merck KGaA Lipid Nanoparticles (LNP) Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 47. Merck KGaA Lipid Nanoparticles (LNP) Product Portfolio
Table 48. Merck KGaA Recent Development
Table 49. Genevant Sciences Company Information
Table 50. Genevant Sciences Business Overview
Table 51. Genevant Sciences Lipid Nanoparticles (LNP) Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 52. Genevant Sciences Lipid Nanoparticles (LNP) Product Portfolio
Table 53. Genevant Sciences Recent Development
Table 54. Exelead Company Information
Table 55. Exelead Business Overview
Table 56. Exelead Lipid Nanoparticles (LNP) Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 57. Exelead Lipid Nanoparticles (LNP) Product Portfolio
Table 58. Exelead Recent Development
Table 59. Avanti Polar Lipids Company Information
Table 60. Avanti Polar Lipids Business Overview
Table 61. Avanti Polar Lipids Lipid Nanoparticles (LNP) Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 62. Avanti Polar Lipids Lipid Nanoparticles (LNP) Product Portfolio
Table 63. Avanti Polar Lipids Recent Development
Table 64. Nippon Fine Chemical Company Information
Table 65. Nippon Fine Chemical Business Overview
Table 66. Nippon Fine Chemical Lipid Nanoparticles (LNP) Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 67. Nippon Fine Chemical Lipid Nanoparticles (LNP) Product Portfolio
Table 68. Nippon Fine Chemical Recent Development
Table 69. Lipoid Company Information
Table 70. Lipoid Business Overview
Table 71. Lipoid Lipid Nanoparticles (LNP) Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 72. Lipoid Lipid Nanoparticles (LNP) Product Portfolio
Table 73. Lipoid Recent Development
Table 74. North America Lipid Nanoparticles (LNP) Revenue by Type (2019-2024) & (US$ Million)
Table 75. North America Lipid Nanoparticles (LNP) Revenue by Application (2019-2024) & (US$ Million)
Table 76. North America Lipid Nanoparticles (LNP) Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 77. North America Lipid Nanoparticles (LNP) Revenue by Country (2019-2024) & (US$ Million)
Table 78. North America Lipid Nanoparticles (LNP) Revenue by Country (2025-2030) & (US$ Million)
Table 79. Europe Lipid Nanoparticles (LNP) Revenue by Type (2019-2024) & (US$ Million)
Table 80. Europe Lipid Nanoparticles (LNP) Revenue by Application (2019-2024) & (US$ Million)
Table 81. Europe Lipid Nanoparticles (LNP) Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 82. Europe Lipid Nanoparticles (LNP) Revenue by Country (2019-2024) & (US$ Million)
Table 83. Europe Lipid Nanoparticles (LNP) Revenue by Country (2025-2030) & (US$ Million)
Table 84. China Lipid Nanoparticles (LNP) Revenue by Type (2019-2024) & (US$ Million)
Table 85. China Lipid Nanoparticles (LNP) Revenue by Application (2019-2024) & (US$ Million)
Table 86. Asia Lipid Nanoparticles (LNP) Revenue by Type (2019-2024) & (US$ Million)
Table 87. Asia Lipid Nanoparticles (LNP) Revenue by Application (2019-2024) & (US$ Million)
Table 88. Asia Lipid Nanoparticles (LNP) Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 89. Asia Lipid Nanoparticles (LNP) Revenue by Country (2019-2024) & (US$ Million)
Table 90. Asia Lipid Nanoparticles (LNP) Revenue by Country (2025-2030) & (US$ Million)
Table 91. MEALA Lipid Nanoparticles (LNP) Revenue by Type (2019-2024) & (US$ Million)
Table 92. MEALA Lipid Nanoparticles (LNP) Revenue by Application (2019-2024) & (US$ Million)
Table 93. MEALA Lipid Nanoparticles (LNP) Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 94. MEALA Lipid Nanoparticles (LNP) Revenue by Country (2019-2024) & (US$ Million)
Table 95. MEALA Lipid Nanoparticles (LNP) Revenue by Country (2025-2030) & (US$ Million)
Table 96. Research Programs/Design for This Report
Table 97. Authors List of This Report
Table 98. Secondary Sources
Table 99. Primary Sources
List of Figures
Figure 1. Lipid Nanoparticles (LNP) Product Picture
Figure 2. Global Lipid Nanoparticles (LNP) Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Lipid Nanoparticles (LNP) Market Size Share 2019 VS 2023 VS 2030
Figure 4. mRNA-lipid Nanoparticle Picture
Figure 5. siRNA-lipid Nanoparticle Picture
Figure 6. Others Picture
Figure 7. Global Lipid Nanoparticles (LNP) Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 8. Global Lipid Nanoparticles (LNP) Market Size Share 2019 VS 2023 VS 2030
Figure 9. Vaccines and Drugs Picture
Figure 10. Scientific Research Picture
Figure 11. Global Lipid Nanoparticles (LNP) Market Size (US$ Million) & (2019-2030)
Figure 12. Global Lipid Nanoparticles (LNP) Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Lipid Nanoparticles (LNP) Market Share by Region: 2019 VS 2023 VS 2030
Figure 14. Global Lipid Nanoparticles (LNP) Players Revenue Share Top 10 and Top 5 in 2023
Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 16. Global Lipid Nanoparticles (LNP) Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Lipid Nanoparticles (LNP) Revenue Market Share 2019 VS 2023 VS 2030
Figure 18. Global Lipid Nanoparticles (LNP) Revenue Market Share by Type (2019-2030)
Figure 19. Global Lipid Nanoparticles (LNP) Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Lipid Nanoparticles (LNP) Revenue Market Share by Application (2019 VS 2023 VS 2030)
Figure 21. Global Lipid Nanoparticles (LNP) Revenue Market Share by Application (2019-2030)
Figure 22. North America Lipid Nanoparticles (LNP) Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Lipid Nanoparticles (LNP) Revenue by Type (2025-2030) & (US$ Million)
Figure 24. North America Lipid Nanoparticles (LNP) Revenue Share by Type (2019-2030)
Figure 25. North America Lipid Nanoparticles (LNP) Revenue by Application (2025-2030) & (US$ Million)
Figure 26. North America Lipid Nanoparticles (LNP) Revenue Share by Application (2019-2030)
Figure 27. North America Lipid Nanoparticles (LNP) Revenue Share by Country (2019-2030)
Figure 28. United States Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 29. Canada Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 30. Europe Lipid Nanoparticles (LNP) Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 31. Europe Lipid Nanoparticles (LNP) Revenue by Type (2025-2030) & (US$ Million)
Figure 32. Europe Lipid Nanoparticles (LNP) Revenue Share by Type (2019-2030)
Figure 33. Europe Lipid Nanoparticles (LNP) Revenue by Application (2025-2030) & (US$ Million)
Figure 34. Europe Lipid Nanoparticles (LNP) Revenue Share by Application (2019-2030)
Figure 35. Europe Lipid Nanoparticles (LNP) Revenue Share by Country (2019-2030)
Figure 36. Germany Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 37. France Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 38. U.K. Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 39. Italy Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 40. Russia Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 41. Nordic Countries Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 42. China Lipid Nanoparticles (LNP) Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 43. China Lipid Nanoparticles (LNP) Revenue by Type (2025-2030) & (US$ Million)
Figure 44. China Lipid Nanoparticles (LNP) Revenue Share by Type (2019-2030)
Figure 45. China Lipid Nanoparticles (LNP) Revenue by Application (2025-2030) & (US$ Million)
Figure 46. China Lipid Nanoparticles (LNP) Revenue Share by Application (2019-2030)
Figure 47. Asia Lipid Nanoparticles (LNP) Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 48. Asia Lipid Nanoparticles (LNP) Revenue by Type (2025-2030) & (US$ Million)
Figure 49. Asia Lipid Nanoparticles (LNP) Revenue Share by Type (2019-2030)
Figure 50. Asia Lipid Nanoparticles (LNP) Revenue by Application (2025-2030) & (US$ Million)
Figure 51. Asia Lipid Nanoparticles (LNP) Revenue Share by Application (2019-2030)
Figure 52. Asia Lipid Nanoparticles (LNP) Revenue Share by Country (2019-2030)
Figure 53. Japan Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 54. South Korea Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 55. India Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 56. Australia Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 57. China Taiwan Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 58. Southeast Asia Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 59. MEALA Lipid Nanoparticles (LNP) Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 60. MEALA Lipid Nanoparticles (LNP) Revenue by Type (2025-2030) & (US$ Million)
Figure 61. MEALA Lipid Nanoparticles (LNP) Revenue Share by Type (2019-2030)
Figure 62. MEALA Lipid Nanoparticles (LNP) Revenue by Application (2025-2030) & (US$ Million)
Figure 63. MEALA Lipid Nanoparticles (LNP) Revenue Share by Application (2019-2030)
Figure 64. MEALA Lipid Nanoparticles (LNP) Revenue Share by Country (2019-2030)
Figure 65. Mexico Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 66. South Korea Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 67. Brazil Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 68. Israel Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 69. Argentina Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 70. Colombia Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 71. Turkey Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 72. Saudi Arabia Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 73. UAE Lipid Nanoparticles (LNP) Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 74. Years Considered
Figure 75. Research Process
Figure 76. Key Executives Interviewed
